发明名称 |
Block copolymer having phenylboronic acid group introduced therein, and use thereof |
摘要 |
A block copolymer includes a polyamino acid chain segment and a hydrophilic polymer chain segment. The polyamino acid chain segment includes at least one amino acid residue having a side chain that contains a cationic group and at least one amino acid residue having a side chain that contains a substituted phenylboronic acid group. In the substituted phenylboronic acid group, at least one hydrogen of the phenyl ring is substituted so that the phenylboronic acid group has a pKa of less than 8. Such a block copolymer serves as a carrier that simultaneously imparts stability to a biotechnology-based drug in blood and provides suitable drug-releasing properties of the drug at an affected area. |
申请公布号 |
US9114177(B2) |
申请公布日期 |
2015.08.25 |
申请号 |
US201214358816 |
申请日期 |
2012.11.19 |
申请人 |
THE UNIVERSITY OF TOKYO;NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY;NANOCARRIER CO., LTD. |
发明人 |
Kataoka Kazunori;Ishii Takehiko;Naito Mitsuru;Matsumoto Akira;Kato Yasuki |
分类号 |
A61K31/713;A61K47/48;C08G81/00;C08G69/40;C08G69/42 |
主分类号 |
A61K31/713 |
代理机构 |
J-Tek Law PLLC |
代理人 |
J-Tek Law PLLC ;Tekanic Jeffrey D.;Wakeman Scott T. |
主权项 |
1. A pharmaceutical composition, comprising a complex of:
a block copolymer having a polyamino acid chain segment and a hydrophilic polymer chain segment, and a nucleic acid, wherein the polyamino acid chain segment includes at least one amino acid residue having a side chain that contains a cationic group and at least one amino acid residue having a side chain that contains a substituted phenylboronic acid group, at least one hydrogen atom of the phenyl ring of the substituted phenylboronic acid group has been substituted so that the substituted phenylboronic acid group has a pKa of less than 8, and the nucleic acid is reversibly covalently bound to the substituted phenylboronic acid group. |
地址 |
Tokyo JP |